ArticlePloS one2022
CdTiO3-NPs incorporated TiO2 nanostructure photocatalyst for scavenger-free water splitting under visible radiation.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 10 citations in OpenAlex.
- Exploring the electrocatalytic potential of CdTiOScientific reports · 2025Article
- Emerging applications of sustainable modified CdO/Ag-CdO NPs for electrochemical sensitive and selective detection of mercury (HgScientific reports · 2025Article
- Advanced strategies for enhancing kaolin ceramics using nanostructured additives: A comprehensive study.PloS one · 2025Article
- Development of a sustainable and disposable modified Bi-CdFeScientific reports · 2024Article
- Synergistic doping with Ag, CdO, and ZnO to overcome electron-hole recombination in TiOFrontiers in chemistry · 2023Article
- Article
- Extraction of Novel Effective Nanocomposite Photocatalyst from Corn Stalk for Water Photo Splitting under Visible Light Radiation.Polymers · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanofibrous morphology and the doping technique can overcome the problem of electron/hole fast recombination and improve the activity of titanium oxide-based photocatalysts. In this study, nanoparticulate and nanofibrous forms of CdTiO3-incorporated TiO2 were synthesized with different cadmium contents; the morphology and composition were determined by SEM, TEM, EDX, and XRD techniques. The nanomorphology, cadmium content, and reaction temperature of Cd-doped TiO2 nanostructures were found to be strongly affect the hydrogen production rate. Nanofibrous morphology improves the rate of hydrogen evolution by around 10 folds over the rate for nanoparticles due to electron confinement in 0D nanostructures. The average rates of hydrogen production for samples of 0.5 wt.% Cd are 0.7 and 16.5 ml/gcat.min for nanoparticles and nanofibers, respectively. On the other hand, cadmium doping resulted in increasing the hydrogen production rate from 9.6 to 19.7 ml/gcat.min for pristine and Cd-doped (2 wt%) TiO2 nanofibers, respectively. May be the formation of type I heterostructures between the TiO2 matrix and CdTiO3 nanoparticles is the main reason for the observed enhancement of photocatalytic activity due to the strong suppressing of electron/holes recombination process. Consequently, the proposed photocatalyst could be exploited to produce hydrogen from scavenger-free solution. Varying reaction temperature suggests that hydrogen evolution over the proposed catalyst is incompatible with the Arrhenius equation. In particular, reaction temperature was found to have a negative influence on photocatalytic activity. This work shows the prospects for using CdTiO3 as a co-catalyst in photon-induced water splitting and indicates a substantial enhancement in the rate of hydrogen production upon using the proposed photocatalyst in nanofibrous morphology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.